BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10863228)

  • 1. Laser treatment of imipramine-induced hyperpigmentation.
    Atkin DH; Fitzpatrick RE
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):77-80. PubMed ID: 10863228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed darkening of imipramine-induced hyperpigmentation after treatment with a Q-switched Nd:YAG laser followed by a Q-switched ruby laser.
    Izikson L; Anderson RR
    Dermatol Surg; 2009 Mar; 35(3):527-9. PubMed ID: 19250303
    [No Abstract]   [Full Text] [Related]  

  • 3. Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser.
    Alster TS; Gupta SN
    Dermatol Surg; 2004 Sep; 30(9):1201-4. PubMed ID: 15355359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipramine-induced hyperpigmentation: a case report and review of the literature.
    D'Agostino ML; Risser J; Robinson-Bostom L
    J Cutan Pathol; 2009 Jul; 36(7):799-803. PubMed ID: 19519613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipramine-induced hyperpigmentation of the skin.
    Mehr N; Wu JJ; Dyson SW; Woseth DM
    Dermatol Online J; 2007 Oct; 13(4):8. PubMed ID: 18319005
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of imipramine-induced dyspigmentation with Q-switched alexandrite laser therapy.
    Orringer JS; Lowe L; Cha KB
    Dermatol Surg; 2010 Sep; 36(9):1469-72. PubMed ID: 20636386
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of nonmelanotic hyperpigmentation with the Q-switched ruby laser.
    Becker-Wegerich PM; Kuhn A; Malek L; Lehmann P; Megahed M; Ruzicka T
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):272-4. PubMed ID: 10906650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment of psychotropic drug-induced facial hyperpigmentation with a 755-nm Q-switched alexandrite laser.
    Wee SA; Dover JS
    Dermatol Surg; 2008 Nov; 34(11):1609-12. PubMed ID: 19021670
    [No Abstract]   [Full Text] [Related]  

  • 9. Imipramine-induced hyperpigmentation: four cases and a review of the literature.
    Ming ME; Bhawan J; Stefanato CM; McCalmont TH; Cohen LM
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):159-66. PubMed ID: 10025739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel hyperpigmentation pathophysiology following a prolonged course of imipramine therapy.
    McKenna B; Wold L; Noland MM; Schenck O
    J Cutan Pathol; 2024 Feb; 51(2):105-107. PubMed ID: 37818708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized chrysiasis induced by laser therapy.
    Trotter MJ; Tron VA; Hollingdale J; Rivers JK
    Arch Dermatol; 1995 Dec; 131(12):1411-4. PubMed ID: 7492130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipramine-induced hyperpigmentation.
    Bicknell LM; McFaddin CL; Fernandez M; Parekh P
    Cutis; 2017 Sep; 100(3):E8-E10. PubMed ID: 29121138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipramine-Induced Cutaneous and Iris Hyperpigmentation: A Case Report and Literature Review.
    Coffey N; Ali Z; Grau J
    Prim Care Companion CNS Disord; 2022 Mar; 24(2):. PubMed ID: 35364629
    [No Abstract]   [Full Text] [Related]  

  • 14. Photodistributed blue-gray pigmentation of the skin associated with long-term imipramine use.
    Angel TA; Stalkup JR; Hsu S
    Int J Dermatol; 2002 Jun; 41(6):327-9. PubMed ID: 12100685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipramine-induced facial pigmentation: case report and literature review.
    Metelitsa AI; Nguyen GK; Lin AN
    J Cutan Med Surg; 2005 Dec; 9(6):341-5. PubMed ID: 17016757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of exogenous ochronosis with a Q-switched alexandrite (755 nm) laser.
    Bellew SG; Alster TS
    Dermatol Surg; 2004 Apr; 30(4 Pt 1):555-8. PubMed ID: 15056151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Laugier-Hunziker syndrome with the Q-switched alexandrite laser in 22 Chinese patients.
    Zuo YG; Ma DL; Jin HZ; Liu YH; Wang HW; Sun QN
    Arch Dermatol Res; 2010 Mar; 302(2):125-30. PubMed ID: 20012075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infraorbital pigmented skin. Preliminary observations of laser therapy.
    Lowe NJ; Wieder JM; Shorr N; Boxrud C; Saucer D; Chalet M
    Dermatol Surg; 1995 Sep; 21(9):767-70. PubMed ID: 7655794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of minocycline-induced cutaneous pigmentation with the Q-switched Alexandrite laser and a review of the literature.
    Green D; Friedman KJ
    J Am Acad Dermatol; 2001 Feb; 44(2 Suppl):342-7. PubMed ID: 11174411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of Q-switched alexandrite laser and intense pulsed light for the treatment of freckles and lentigines in Asian persons: a randomized, physician-blinded, split-face comparative trial.
    Wang CC; Sue YM; Yang CH; Chen CK
    J Am Acad Dermatol; 2006 May; 54(5):804-10. PubMed ID: 16635661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.